Canopy Growth (CGC) Income from Non-Controlling Interests (2019 - 2025)

Canopy Growth (CGC) reported Income from Non-Controlling Interests of $95.5 million for Q4 2025, up 965.96% sequentially from -$11.0 million in Q3 2023.

Canopy Growth (CGC) Income from Non-Controlling Interests (2019 - 2025) Analysis & Trends

Canopy Growth (CGC) has 6 years of Income from Non-Controlling Interests data on file, last reported at $95.5 million in Q4 2025.

  • For the quarter ending Q4 2025, Income from Non-Controlling Interests changed N/A year-over-year to $95.5 million; the trailing twelve-month figure through Dec 2025 stood at $84.5 million (changed N/A YoY), and the FY2025 full-year result was -$1.3 million, changed N/A from the prior year.
  • Income from Non-Controlling Interests climbed to $95.5 million in Q4 2025, from -$11.0 million in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $95.5 million in Q4 2025 to a low of -$11.0 million in Q3 2023.
  • A 4-year average of $4.7 million and a median of -$3.7 million in 2022 frame the typical range for Income from Non-Controlling Interests.
  • Across the five-year window, Income from Non-Controlling Interests jumped 198.06% in 2022 and plunged 1015.95% in 2023, its largest moves.
  • Tracing CGC's Income from Non-Controlling Interests over 4 years: stood at -$5.2 million in 2021, then surged by 38.26% to -$3.2 million in 2022, then tumbled by 242.67% to -$11.0 million in 2023, then soared by 965.96% to $95.5 million in 2025.
  • Business Quant data shows CGC's Income from Non-Controlling Interests at $95.5 million in Q4 2025, -$11.0 million in Q3 2023, and -$2.8 million in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 395,346.10
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -12.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Canopy Growth 276.52 Mn 10.60 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 95.51 Mn
Sep 30, 2023 -11.03 Mn
Jun 30, 2023 -2.78 Mn
Mar 31, 2023 -5.57 Mn
Dec 31, 2022 -3.22 Mn
Sep 30, 2022 -988,335.91
Jun 30, 2022 -4.16 Mn
Mar 31, 2022 6.89 Mn
Dec 31, 2021 -5.21 Mn
Sep 30, 2021 -4.19 Mn
Jun 30, 2021 -2.00 Mn
Mar 31, 2021 -7.03 Mn
Dec 31, 2020 57.63 Mn
Sep 30, 2020 -48.40 Mn
Jun 30, 2020 -7.69 Mn
Mar 31, 2020 -17.44 Mn
Dec 31, 2019 -13.85 Mn
Sep 30, 2019 -12.33 Mn
Jun 30, 2019 -6.12 Mn